Top compounds associated with response to AIF1


Feature Type Standardized
Nominal ANOVA
mRNA XL-184 GDSC1000 pan-cancer AAC 0.21 3e-07
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.19 3e-07
mRNA ZM-447439 GDSC1000 pan-cancer AAC 0.21 7e-07
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.18 7e-07
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA Teniposide CTRPv2 pan-cancer AAC 0.21 2e-06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.27 2e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA GSK-650394 GDSC1000 pan-cancer AAC 0.2 3e-06
Download CSV